LONDON, 2 October 2013
(IRIN) - One of the biggest hurdles to stemming the global tide of counterfeit
medicines is disagreement over the term itself, which drug companies are accused
of hijacking for commercial rather than public health reasons. Read
report online
No comments:
Post a Comment